This Gene Therapy Could Help Treat Blindness

  • Trial results for Spark Therapeutics therapy shown in Paris
  • Eye medicine could become first FDA-approved gene therapy drug

A gene therapy maker showed this week it could make blind children and adults see. But the big question left is how long the effect will last.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.